HomeAGNPF • OTCMKTS
add
Algernon Pharmaceuticals Inc
Previous close
$0.043
Day range
$0.049 - $0.054
Year range
$0.036 - $0.093
Market cap
2.40M CAD
Avg Volume
9.69K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
BTC / USD
0.014%
0.41%
Financials
Income Statement
Revenue
Net income
(CAD) | May 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 543.79K | 22.95% |
Net income | -583.22K | -140.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -535.13K | -22.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | May 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 88.18K | -85.53% |
Total assets | 4.88M | 25.38% |
Total liabilities | 3.14M | 62.58% |
Total equity | 1.74M | — |
Shares outstanding | 29.04M | — |
Price to book | 0.71 | — |
Return on assets | -32.92% | — |
Return on capital | -86.12% | — |
Cash Flow
Net change in cash
(CAD) | May 2025info | Y/Y change |
---|---|---|
Net income | -583.22K | -140.39% |
Cash from operations | -174.52K | 90.23% |
Cash from investing | 175.00K | -92.41% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -4.00K | -100.75% |
Free cash flow | 701.90K | 137.84% |
About
Founded
2015
Headquarters
Website